Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF‐κB pathway in a rat model of myocardial infarction. Issue 2 (8th February 2018)
- Record Type:
- Journal Article
- Title:
- Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF‐κB pathway in a rat model of myocardial infarction. Issue 2 (8th February 2018)
- Main Title:
- Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF‐κB pathway in a rat model of myocardial infarction
- Authors:
- Sun, Yiping
Xie, Ying
Du, Luping
Sun, Jingwu
Liu, Zhiqiang - Abstract:
- Summary: Background: Myocardial infarction (MI) remains the most common cause of heart failure (HF) worldwide. For almost 50 years, HF has been recognized as a determinant of adverse prognosis after MI, but efforts to promote myocardial repair have failed to be translated into clinical therapies. Aims: In this study, we investigated the effects of BRD4 on cardiac function and the underlying mechanism. Material and Methods: The in vivo rat model of AMI and in vitro neonatal cardiomyocytes were established and cultured respectively, the BRD4 and NPPA/NPPB expression levels were detected by qPCR and Western blot, and interaction of BRD4 with acetylation RelA or NPPA/B promoters were examined by co‐immunoprecipitation and chromatin immunoprecipitation assays, respectively. Results: We found that BRD4 protein expression was significantly increased in cardiomyocytes of MI rat model and cardiomyocytes under hypoxia, accompanied by the expression of natriuretic peptide A (NPPA) and natriuretic peptide B (NPPB). Functionally, knockdown of BRD4 greatly downregulated the NPPA and NPPB in vivo and in vitro, improved the hemodynamic and biometric parameters in rat with heart failure, as well as decreased the apoptosis occurrence. In vitro studies further demonstrated that BRD4 bound with acetylated RelA to enhance the activation of NF‐κb signaling, which resulted in activation of NPPA and NPPB transcriptions. Conclusions: Taken together, our findings suggest that inhibition of BRD4Summary: Background: Myocardial infarction (MI) remains the most common cause of heart failure (HF) worldwide. For almost 50 years, HF has been recognized as a determinant of adverse prognosis after MI, but efforts to promote myocardial repair have failed to be translated into clinical therapies. Aims: In this study, we investigated the effects of BRD4 on cardiac function and the underlying mechanism. Material and Methods: The in vivo rat model of AMI and in vitro neonatal cardiomyocytes were established and cultured respectively, the BRD4 and NPPA/NPPB expression levels were detected by qPCR and Western blot, and interaction of BRD4 with acetylation RelA or NPPA/B promoters were examined by co‐immunoprecipitation and chromatin immunoprecipitation assays, respectively. Results: We found that BRD4 protein expression was significantly increased in cardiomyocytes of MI rat model and cardiomyocytes under hypoxia, accompanied by the expression of natriuretic peptide A (NPPA) and natriuretic peptide B (NPPB). Functionally, knockdown of BRD4 greatly downregulated the NPPA and NPPB in vivo and in vitro, improved the hemodynamic and biometric parameters in rat with heart failure, as well as decreased the apoptosis occurrence. In vitro studies further demonstrated that BRD4 bound with acetylated RelA to enhance the activation of NF‐κb signaling, which resulted in activation of NPPA and NPPB transcriptions. Conclusions: Taken together, our findings suggest that inhibition of BRD4 attenuated cardiomyocyte apoptosis via NF‐κB pathway in myocardial infarction, and this study sheds light on developing new strategies to overcome myocardial damage. … (more)
- Is Part Of:
- Cardiovascular therapeutics. Volume 36:Issue 2(2018)
- Journal:
- Cardiovascular therapeutics
- Issue:
- Volume 36:Issue 2(2018)
- Issue Display:
- Volume 36, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 36
- Issue:
- 2
- Issue Sort Value:
- 2018-0036-0002-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2018-02-08
- Subjects:
- BRD4 -- myocardial infarction -- NF‐κB signaling -- RelA acetylation
Cardiovascular pharmacology -- Periodicals
Cardiovascular agents -- Periodicals
Cardiovascular system -- Diseases -- Chemotherapy -- Periodicals
Cardiovascular Agents -- Periodicals
Cardiovascular Diseases -- drug therapy -- Periodicals
Agents cardiovasculaires -- Périodiques
Appareil cardiovasculaire -- Maladies -- Chimiothérapie -- Périodiques
616.1005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1755-5922 ↗
http://www.blackwell-synergy.com/loi/cath ↗
http://www.blackwellpublishing.com/journal.asp?ref=1755-5914&site=1 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1755-5922.12320 ↗
- Languages:
- English
- ISSNs:
- 1755-5914
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3051.520500
British Library HMNTS - ELD Digital store - Ingest File:
- 5968.xml